/// Resources ///
News, Tools & Analysis
The latest from ABI and the people making the case for American medicine: our policy framework, op-eds and remarks from our leaders and advisors, research prepared for ABI, our own analysis, and a policy simulation that lets you test the choices yourself.
/// Featured ///
The Policy Framework
American Biosecurity Initiative
October 2026
Securing America’s Biotechnology Leadership
A Policy Framework to Enhance U.S. Biosecurity
Policy Framework · Oct 2026
Securing America’s Biotechnology Leadership
America remains the world’s biotechnology leader, but China is catching up fast. The framework sets out what Washington should do about it: three pillars and 23 recommendations for Congress and the executive branch, each tied to a national security objective.
Strengthen America’s research ecosystem. Modernize regulations to move at the speed of science. Forge resilient supply chains with trusted partners.
/// On the Record ///
On the Record
The public case for American biosecurity, in the words of the people making it. Op-eds, remarks, statements, testimony, and video.
ABI Releases Policy Agenda to Strengthen U.S. Biotech Leadership
"China treats biotechnology as a national security priority, and the United States should too."
Read ›
America's Biotech Race With China Must Be Won at Home
Washington needs a strategy "that takes America's biotech ambitions as seriously as China takes its own."
Read ›
The Wrong Way To Compete With China in Biotech
"Making China weaker is not the same as making America stronger."
Read ›
The China Biotech Debate
ABI served as executive sponsor of the Endpoints News China Biotech Debate, where Executive Director Jennifer Crook delivered the opening remarks. Video of her remarks is coming.
/// Intelligence ///
Latest Analysis
Sample · Live Posts Replace These
Why Medicine Is National Security
The case for treating the discovery and manufacture of American medicine as a national security asset.
Read ›
Two Pressures, One Base
Competition from adversary states abroad and policy drift at home, and why both have to be named at once.
Read ›
Build Strength, Not Walls
Why lasting supply security comes from a stronger America and trusted partners, not protectionism.
Read ›
/// Reports and Coverage ///
Reports & Coverage
Research prepared for ABI, and the reporting and analysis that sharpen the case.
Securing America’s Biotechnology Leadership
A policy framework to enhance U.S. biosecurity. Three pillars and 23 recommendations for Congress and the executive branch.
Regaining American Biotechnology Strength
The state of U.S. biosecurity. Prepared for ABI by Start Grow Remain, with an annotated literature map.
Why America's Medicine Became a National Security Question
ABI's case in Endpoints News: the ability to discover, develop, and make medicine is a national security asset, and the way to protect it is building strength, not walls.
/// Interactive ///
The Policy Simulation
Keep America Competitive and Secure
Eight policy moves, each with a case and a cost. Choose a mix and see whether it builds strength or ends in shortage.